Latest Ratios: P/E Ratio 38.7x · EV/EBITDA 15.4x · ROE -2.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $168M | $91M | $105M | $160M | $112M | $136M | $67M | $62M | $64M | $89M | $48M |
| Enterprise Value | $171M | $94M | $111M | $132M | $121M | $142M | $64M | $59M | $46M | $76M | $19M |
| P/E Ratio → | 38.65 | — | 35.79 | 17.22 | 13.21 | 18.71 | — | 27.05 | 21.14 | 96.11 | 17.69 |
| P/S Ratio | 1.23 | 0.80 | 0.80 | 1.30 | 0.96 | 1.61 | 1.24 | 1.02 | 0.81 | 1.34 | 1.18 |
| P/B Ratio | 1.57 | 0.88 | 1.05 | 1.66 | 1.72 | 2.49 | 1.49 | 1.38 | 1.48 | 2.28 | 1.26 |
| P/FCF | — | 16.04 | 42.10 | 10.74 | — | 13.86 | 25.70 | — | 7.28 | 13.77 | 12.04 |
| P/OCF | 22.97 | 12.46 | 27.51 | 9.89 | — | 12.59 | 20.49 | — | 5.81 | 12.35 | 11.08 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.83 | 0.85 | 1.07 | 1.04 | 1.67 | 1.18 | 0.98 | 0.58 | 1.14 | 0.47 |
| EV / EBITDA | 15.36 | 30.58 | 12.67 | 8.76 | 7.83 | 12.24 | 32.47 | 23.27 | 6.49 | 14.13 | 3.99 |
| EV / EBIT | — | — | 25.89 | 11.29 | 11.22 | 16.72 | 934.59 | 21.27 | 3.79 | 7.19 | 4.56 |
| EV / FCF | — | 16.53 | 44.59 | 8.88 | — | 14.42 | 24.54 | — | 5.23 | 11.72 | 4.79 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.0% | 43.0% | 42.4% | 46.2% | 45.7% | 48.6% | 44.8% | 48.2% | 50.2% | 51.9% | 50.7% |
| Operating Margin | -3.3% | -3.3% | 2.6% | 8.5% | 9.2% | 10.0% | -2.3% | -1.1% | 6.6% | 5.4% | 10.3% |
| Net Profit Margin | -2.2% | -2.2% | 2.2% | 7.6% | 7.2% | 8.6% | -1.7% | 3.8% | 3.9% | 1.5% | 6.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -2.5% | -2.5% | 2.9% | 11.6% | 14.1% | 14.6% | -2.0% | 5.3% | 7.4% | 2.5% | 7.2% |
| ROA | -1.7% | -1.7% | 2.0% | 7.6% | 7.9% | 8.8% | -1.5% | 3.7% | 4.7% | 1.9% | 6.4% |
| ROIC | -2.6% | -2.6% | 2.9% | 11.0% | 12.0% | 12.4% | -2.2% | -1.4% | 15.2% | 15.4% | 32.1% |
| ROCE | -3.2% | -3.2% | 2.9% | 10.8% | 13.2% | 12.8% | -2.3% | -1.3% | 11.0% | 8.4% | 11.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.16 | 0.16 | 0.26 | 0.18 | 0.35 | 0.49 | 0.16 | 0.11 | — | — | — |
| Debt / EBITDA | 5.53 | 5.53 | 2.96 | 1.15 | 1.46 | 2.30 | 3.71 | 2.00 | — | — | — |
| Net Debt / Equity | — | 0.03 | 0.06 | -0.29 | 0.14 | 0.10 | -0.07 | -0.06 | -0.42 | -0.34 | -0.76 |
| Net Debt / EBITDA | 0.90 | 0.90 | 0.71 | -1.84 | 0.59 | 0.48 | -1.54 | -0.99 | -2.53 | -2.47 | -6.03 |
| Debt / FCF | — | 0.48 | 2.49 | -1.86 | — | 0.56 | -1.16 | — | -2.04 | -2.05 | -7.25 |
| Interest Coverage | -6.16 | -6.16 | 5.08 | 17.27 | 16.98 | 95.40 | — | — | 88.18 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.20 | 2.20 | 2.47 | 3.53 | 2.23 | 2.08 | 3.04 | 2.98 | 1.66 | 2.15 | 7.52 |
| Quick Ratio | 1.32 | 1.32 | 1.63 | 2.70 | 1.40 | 1.56 | 2.20 | 2.12 | 1.36 | 1.81 | 6.79 |
| Cash Ratio | 0.40 | 0.40 | 0.62 | 1.86 | 0.50 | 0.85 | 1.16 | 0.91 | 0.83 | 0.92 | 5.66 |
| Asset Turnover | — | 0.75 | 0.86 | 0.91 | 1.06 | 0.82 | 0.87 | 1.02 | 1.17 | 1.07 | 0.94 |
| Inventory Turnover | 2.06 | 2.06 | 2.80 | 3.30 | 2.81 | 3.39 | 3.98 | 4.38 | 6.01 | 6.47 | 5.40 |
| Days Sales Outstanding | — | 83.02 | 82.38 | 53.80 | 66.28 | 71.11 | 57.20 | 55.94 | 49.08 | 66.47 | 48.79 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.6% | — | 2.8% | 5.8% | 7.6% | 5.3% | — | 3.7% | 4.7% | 1.0% | 5.7% |
| FCF Yield | — | 6.2% | 2.4% | 9.3% | — | 7.2% | 3.9% | — | 13.7% | 7.3% | 8.3% |
| Buyback Yield | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.8% | 0.0% | 0.1% | 2.1% |
| Total Shareholder Yield | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.1% | 1.8% | 0.0% | 0.1% | 2.1% |
| Shares Outstanding | — | $12M | $12M | $12M | $11M | $11M | $10M | $10M | $10M | $10M | $10M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying INTT stock.
inTEST Corporation's current P/E ratio is 38.7x. The historical average is 21.5x. This places it at the 95th percentile of its historical range.
inTEST Corporation's current EV/EBITDA is 15.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.3x.
inTEST Corporation's return on equity (ROE) is -2.5%. The historical average is 6.8%.
Based on historical data, inTEST Corporation is trading at a P/E of 38.7x. This is at the 95th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
inTEST Corporation has 43.0% gross margin and -3.3% operating margin.
inTEST Corporation's Debt/EBITDA ratio is 5.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Near-zero returns on invested capital
Metrics are mathematically derived from official filings.
Margin Recovery Lacks Earnings Substance
Despite 25.5% YoY revenue growth, 2026Q2 operating and net margins of just 1.0% and 1.3% compare with a 10-quarter peak of 5.7%, per inTEST's reported statements, indicating the revenue recovery has not yet converted into meaningful earning power.
The margin structure reveals that gross margin, not volume, is the swing factor: it compressed 490 bps from the 45.4% print in 2025Q4 to 40.5% in 2026Q2, entirely offsetting the benefit of sequential revenue gains. With SG&A fixed near $10 million as established in the income statement review, gross margin volatility flows almost one-for-one to operating profit, which is why operating income sat at only $363K on $35.3 million of revenue. For analytical purposes, mid-cycle operating margin — not the TTM figure — appears the more defensible measure of INTT's earning capacity, and it remains in the low-to-mid single digits.
Capital Returns Sit at Apathy Levels
ROIC has oscillated between -2.1% and 1.4% across ten quarters, closing at 0.3% in 2026Q2 versus ACMR's 7.0% and NVEC's 21.2%, based on the peer and ratio data provided, implying capital is being deployed without measurable value creation.
The persistently sub-1% ROIC is driven overwhelmingly by the margin denominator rather than asset intensity: with asset turnover stuck near 0.24, even the best quarters of the cycle generate only high-single-digit returns on sales, which caps ROIC near 1.4%. The implication is that the modest deleveraging documented in the balance sheet review has not improved the returns profile, because the constraint is earnings generation rather than capital structure. Investors should note the equity build of roughly $8.4 million came largely from outside retained profits, so rising book capital against flat earnings mathematically dilutes ROE toward the 0.4% observed.
Working Capital Absorbs Fifteen Weeks of Sales
inTEST's cash conversion cycle held near 163 days in 2026Q2, with days inventory outstanding of 126 against a days payable outstanding of only 37, according to the reported quarterly ratio data, marking a structurally heavy inventory position for a test-equipment manufacturer.
The CCC has remained elevated across the full ten-quarter window, ranging from 156 to 210 days, which suggests the inventory build is structural rather than a one-off positioning bet. Asset turnover of 0.24 means roughly four years of sales are tied up in the asset base, and with net PP&E declining to $13.1 million, the balance sheet is increasingly composed of inventory and goodwill rather than productive fixed assets. This pattern explains the cash flow volatility identified earlier: working-capital timing, not end demand, produces the wild FCF swings between -$15.9% and +19.9% margins.
Low Debt Masks Fragile Coverage
Debt-to-equity fell to 0.14 by 2026Q2 from 0.33 in 2024Q2, yet the debt-to-EBITDA ratio spiked to 47.4x and interest coverage slipped to 4.95x from 17.4x two quarters earlier, per inTEST's quarterly filings, because earnings contracted faster than borrowings were repaid.
The divergence between falling absolute leverage and deteriorating coverage metrics is the key analytical point: $14.8 million of debt is modest in isolation, but against an EBITDA base thin enough to produce a 1.0% operating margin, the debt load is functionally much larger than the D/E ratio suggests. Coverage of 4.95x remains serviceable and the $22.1 million cash balance plus 2.49x current ratio provide ample缓冲, so near-term refinancing risk appears low. The exposure is cyclical: a renewed semiconductor downcycle of the 2025 vintage would compress EBITDA further and could push coverage below comfort levels even without new borrowing.
Multiples Price Recovery That Margins Deny
At 66.8x trailing EV/EBITDA versus a 15.5x forward figure, and a forward P/E of 34.5x against a negative trailing P/E of -76.7x, the market is paying for an earnings recovery that the 1.0% operating margin has yet to demonstrate, per the quoted valuation data.
The valuation gap between trailing and forward multiples implicitly assumes EBITDA roughly quadruples; on the historical evidence of ten quarters in which operating margin never sustained above 5%, that is a demanding assumption rather than an observed trend. Against semicap peers, INTT's 1.90x P/B and 1.78x P/S look inexpensive versus NVEC (6.84x P/B) and broadly in line with ACMR (1.85x), but this comparison obscures that peers generate positive and materially higher returns on capital. The implied premium is best framed as an option on operating leverage that has not appeared across a full cycle.
The P/E Misleads in Both Directions
The trailing P/E of -76.7x is the ratio most commonly misapplied to INTT, since near-zero earnings on a cyclical, high-fixed-cost manufacturer make the multiple either meaningless or deceptively extreme, masking rather than revealing the company's underlying economic trajectory.
A negative P/E at trough earnings tells an analyst nothing about value; it fluctuates wildly on small denominator moves, as shown by net margin swinging from -8.7% to +4.1% within six quarters. The appropriate substitute is mid-cycle EV/Sales or a normalized EV/EBITDA anchored to through-cycle gross margins of roughly 42-43% and an assumed mid-single-digit operating margin, which would place the current price materially lower than the 15.5x forward figure implies. Relatedly, the 35.6x P/FCF should be treated cautiously, since the cash flow statement review established that operating cash flow of $14.1 million reflects depreciation add-backs and working-capital releases rather than the $1.6 million of cumulative net income, and stock compensation of $4.6 million further dilutes per-share economics.